Trial intelligence / Profile preview

Phase 3 randomized blinded multicenter trial of NexoBrid versus gel and standard of care for thermal burns

MOH_2017-11-26_001974Phase 3Completed

Sponsor
MediWound
Start
Jun 2014
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of bromelain in thermal injury (3 arms), sponsored by MediWound. Started Jun 2014; status: completed.

02

Drugs

bromelain
03

Conditions

thermal injury

Beyond the preview

Go deeper on MOH_2017-11-26_001974.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2017-11-26_001974.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call